These Three Toilet Detection Health Technology Will Be In The United States, Israel, Japan Clinical Trials

Y Diwydiant Cegin Ac Ystafell Ymolchi Prif Ffrwd Cyfryngau Cegin Ac Ystafell Ymolchi Gwybodaeth

Israeli digital health startup OutSense was awarded a number of key innovation patents for IoT technology, foreign media reported on June 23. The technology gains life-saving medical insights by analyzing human excrement. Mae'r cwmni wedi ffeilio cyfres o dri patent sy'n cwmpasu elfennau o'i synhwyrydd toiled meddygol.

The first OutSense patent is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet bowl to determine the optical signature of hidden blood in feces. Patents for this technology have been granted in the United States, Ewrop, Japan a Tsieina. A second patent has been granted in Europe and applications are pending for this patent in other countries. It allows effective analysis of the spatial distribution of the many components of stool and traces of blood. Based on this analysis, Gall technoleg OutSense nodi ffynhonnell y gwaed ar hyd y llwybr gastroberfeddol. A third patent is pending for the technology, which detects urine dehydration components by analyzing urine and feces.

Yn ôl Prif Swyddog Gweithredol OutSense Yfat Scialom, he predicts that “gyda ffrwydrad meddygaeth ddigidol. This kind of monitoring will become the norm.” OutSense says the technology, which has already been approved and is pending approval, will provide broad protection for a person’s health by non-invasively extracting hidden blood from feces and urine. Hidden blood is critical for detecting colorectal cancer, clefyd llidiol y coluddyn a heintiau'r llwybr wrinol. Its solution includes a multispectral optical sensor, ffynhonnell golau a dyfais sgrinio ymreolaethol sy'n cynnwys cysylltiad WiFi. The device scans human feces and identifies the optical footprint of fecal and urine components. It sends the data to an artificial intelligence-based cloud analysis, which then provides signs of various diseases with great precision.

OutSense develops tools to diagnose abnormalities in human feces. Gwybodaeth a gafwyd o waed a samplwyd, ynghyd â dadansoddiad ychwanegol o'r amser o waedu i ysgarthiad, yn darparu manylion y patholeg gwaedu. Its specific patterns can determine whether the bleeding is from a fissure or hemorrhoid, or from a polyp, tumor or from an ulcer. In early June, Cyhoeddodd OutSense fod CommuniCare, cwmni gofal iechyd mawr gyda mwy na 90 medical facilities in the United States, yn dechrau treialu ei dechnoleg eleni. Yn ogystal â'r peilot hwn, OutSense plans to conduct clinical trials in Israel and Japan.